Glenn R. Mattes, President and CEO at TFF Pharmaceuticals, Inc. (TFFP), sold 108,830 shares at $15.00 ($1.6M) on 2020-11-10, disclosed to the SEC on 2020-11-13.
Open-market sale of $1.6M TFFP by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TFFP | SELL | 2021-03-17 | $852K | — | Filing → |
| TFFP | SELL | 2021-02-18 | $673K | — | Filing → |
| TFFP | SELL | 2021-01-20 | $1.5M | — | Filing → |